FDA Inspection
Abbvie Ireland NL B.V.Abbvie Ireland NL B.V. – FDA Inspection, Aug 29, 2019
Record Details
This FDA Inspection record concerns Abbvie Ireland NL B.V., with an inspection on August 29, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a89be99f-7bd4-47f7-b2b1-2622fe0dea97
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1105474
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Abbvie Ireland NL B.V.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 14, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Abbvie Ireland NL B.V.
- FDA Inspection 1253298 - 2022-12-14
- FDA Inspection 1124019 - 2020-02-28
- FDA Inspection 1000859 - 2017-01-20
- FDA Inspection 899864 - 2014-09-12
- FDA Inspection 717041 - 2011-03-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.